Back to Search Start Over

Genetic variability of the forkhead box O3 and prostate cancer risk in the European Prospective Investigation on Cancer

Authors :
Rudolf Kaaks
Eva Ardanaz
Heiner Boeing
María José Sánchez
Domenico Palli
Nicholas J. Wareham
Tina Karapetyan
Sabina Sieri
Mazda Jenab
Nina Roswall
Kim Overvad
Anne Tjønneland
Ruth C. Travis
Afshan Siddiq
José María Huerta
Anika Hüsing
Angelika Stein
H. Bas Bueno-de-Mesquita
Federico Canzian
Nerea Larrañaga
Mattias Johansson
Kay-Tee Khaw
Lucie Dostal
Jane Nautrup Østergaard
David Cox
Laudina Rodríguez
Daniele Campa
Rosario Tumino
Catalina Bonet
Per Lenner
Naomi E. Allen
Paolo Vineis
Dimosthenis Zylis
Dagmar Drogan
Antonia Trichopoulou
Department of Cancer Epidemiology
German Cancer Research Center - Deutsches Krebsforschungszentrum [Heidelberg] (DKFZ)
Department of Epidemiology
German Institute of Human Nutrition Potsdam-Rehbruecke
German Institute of Human Nutrition Potsdam-Rehbrücke
German Institute of Human Nutrition Potsdam-Rehbrücke (DIfE)
Cancer Epidemiology Institute
Danish Cancer Society
Department of Cardiology
Aarhus University Hospital
Public Health and Participation Directorate
Health and Health Care Services Council
Catalan Institute of Oncology
Consorcio de Investigación Biomédica en Red especializado en Epidemiología y Salud Pública (CIBERESP)
Los Centros de Investigación Biomédica en Red (CIBER)
Granada Cancer Registry
Andalusian School of Public Health [Granada]
Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP)
CIBER de Epidemiología y Salud Pública (CIBERESP)
Murcia Regional Health Authority
Navarra Public Health Institute
Leyre 15
School of Clinical Medicine
University of Cambridge [UK] (CAM)
Epidemiology Unit
Medical Research Council
Cancer Epidemiology Unit
University of Oxford [Oxford]-Cancer Epidemiology Unit
Department of Hygiene, Epidemiology and Medical Statistics
Molecular and Nutritional Epidemiology Unit
ISPO-Cancer Research and Prevention Institute
Nutritional Epidemiology Unit
Fondazione IRCCS Istituto Nazionale dei Tumori
Cancer Registry
Civile - M.P.Arezzo Hospital
Centre for Environment and Health
Imperial College London-School of public health
The University of Hong Kong (HKU)-The University of Hong Kong (HKU)
Human Genetics Foundation (HuGeF)
Università degli studi di Torino (UNITO)
National Institute for Public Health and the Environment [Bilthoven] (RIVM)
Department of Oncology and Radiation Sciences, Oncology
Umea University Hospital
Unit of Nutrition, Environment, and Cancer
Equipe 6
Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL)
Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL)
Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL)
Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Department of Epidemiology and Biostatistics
Imperial College London-Faculty of Medicine-School of public health
The University of Hong Kong (HKU)-The University of Hong Kong (HKU)-Imperial College London-Faculty of Medicine-School of public health
Department of Epidemiology and Biostatistics
Department of Genomics of Common Disease
Division of Cancer Epidemiology
German Cancer Research Center
German Cancer Research Center (DKFZ)
Aalborg Hospital-Aarhus University Hospital
Consorcio de Investigación Biomédica en Red especializado en Epidemiología y Salud Pública ( CIBERESP )
Andalusian School of Public Health
University of Cambridge [UK] ( CAM )
Azienda Ospedaliera 'Civile M.P.Arezzo'
Human Genetics Foundation ( HuGeF )
Università degli studi di Torino ( UNITO )
National Institute for Public Health and the Environment [Bilthoven] ( RIVM )
Centre de Recherche en Cancérologie de Lyon ( CRCL )
Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 ( UCBL )
Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ) -Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 ( UCBL )
Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ) -Department of Epidemiology and Biostatistics
Imperial College London-Faculty of Medicine-School of public health-Imperial College London-Faculty of Medicine-School of public health
Source :
Oncology Reports, Oncology Reports, Spandidos Publications, 2011, 26 (4), pp.979-86. ⟨10.3892/or.2011.1359⟩, Oncology Reports, Spandidos Publications, 2011, 26 (4), pp.979-86. 〈10.3892/or.2011.1359〉, Campa, D, Hüsing, A, Dostal, L, Stein, A, Drogan, D, Boeing, H, Tjønneland, A, Roswall, N, Østergaard, J N, Overvad, K, Rodríguez, L, Bonet, C, Sánchez, M-J, Larrañaga, N, Huerta, J M, Ardanaz, E, Khaw, K-T, Wareham, N, Travis, R C, Allen, N E, Trichopoulou, A, Zylis, D, Karapetyan, T, Palli, D, Sieri, S, Tumino, R, Vineis, P, Bueno-de-Mesquita, H B, Lenner, P, Johansson, M, Jenab, M, Cox, D, Siddiq, A, Kaaks, R & Canzian, F 2011, ' Genetic variability of the forkhead box O3 and prostate cancer risk in the European Prospective Investigation on Cancer ', Oncology Reports, vol. 26, no. 4, pp. 979-986 . https://doi.org/10.3892/or.2011.1359
Publication Year :
2016

Abstract

International audience; Forkhead box O3 (FOXO3) has a wide range of functions: it promotes tumor suppression, cell cycle arrest, repair of damaged DNA, detoxification of reactive oxygen species, apoptosis and plays a pivotal role in promoting longevity. FOXO3 is a key downstream target of the PI3K-Akt pathway in response to cellular stimulation by growth factors or insulin and has been proposed as a bridge between ageing and tumor suppression. Three SNPs in the FOXO3 gene (rs3800231, rs9400239 and rs479744) that have been shown to be strongly and consistently associated with longevity, were examined in relation to PC risk in a case control study of 1571 incident PC cases and 1840 controls nested within the European Prospective Investigation into Cancer and Nutrition (EPIC). There was no statistically significant association between the SNPs and PC risk regardless of the model of inheritance (dominant, codominant and recessive). The associations were not modified by disease aggressiveness, circulating levels of steroid sex hormones, or IGFs or BMI. We conclude that polymorphisms in the FOXO3 gene that are associated with longevity are not major risk factors for PC risk, in this population of Caucasian men.

Subjects

Subjects :
Oncology
Male
MESH: Signal Transduction
Cancer Research
MESH : Aged
MESH : Genotype
030204 cardiovascular system & hematology
[ SDV.CAN ] Life Sciences [q-bio]/Cancer
Cohort Studies
MESH: Genotype
Prostate cancer
0302 clinical medicine
Risk Factors
MESH: Risk Factors
genetic variability
MESH: Cohort Studies
media_common
MESH: Aged
0303 health sciences
education.field_of_study
MESH: Middle Aged
MESH: Polymorphism, Single Nucleotide
MESH : Polymorphism, Single Nucleotide
Forkhead Box Protein O3
Longevity
MESH: Genetic Predisposition to Disease
Forkhead Transcription Factors
General Medicine
MESH: European Continental Ancestry Group
MESH : Adult
Middle Aged
prostate cancer
MESH : Risk Factors
MESH: Case-Control Studies
3. Good health
European Prospective Investigation into Cancer and Nutrition
forkhead box
MESH : Forkhead Transcription Factors
Europe
FOXO3
MESH : Prostatic Neoplasms
Signal Transduction
Adult
medicine.medical_specialty
MESH : Case-Control Studies
Genotype
media_common.quotation_subject
MESH : Male
Population
MESH : Europe
MESH : Cohort Studies
Single-nucleotide polymorphism
[SDV.CAN]Life Sciences [q-bio]/Cancer
Biology
Polymorphism, Single Nucleotide
White People
MESH : European Continental Ancestry Group
03 medical and health sciences
MESH: Forkhead Transcription Factors
Internal medicine
medicine
Humans
MESH : Middle Aged
Genetic Predisposition to Disease
education
030304 developmental biology
Aged
MESH : Signal Transduction
MESH: Humans
MESH : Humans
Case-control study
Cancer
Prostatic Neoplasms
MESH: Adult
medicine.disease
MESH: Male
Case-Control Studies
MESH: Prostatic Neoplasms
MESH : Genetic Predisposition to Disease
MESH: Europe

Details

Language :
English
ISSN :
1021335X
Database :
OpenAIRE
Journal :
Oncology Reports, Oncology Reports, Spandidos Publications, 2011, 26 (4), pp.979-86. ⟨10.3892/or.2011.1359⟩, Oncology Reports, Spandidos Publications, 2011, 26 (4), pp.979-86. 〈10.3892/or.2011.1359〉, Campa, D, Hüsing, A, Dostal, L, Stein, A, Drogan, D, Boeing, H, Tjønneland, A, Roswall, N, Østergaard, J N, Overvad, K, Rodríguez, L, Bonet, C, Sánchez, M-J, Larrañaga, N, Huerta, J M, Ardanaz, E, Khaw, K-T, Wareham, N, Travis, R C, Allen, N E, Trichopoulou, A, Zylis, D, Karapetyan, T, Palli, D, Sieri, S, Tumino, R, Vineis, P, Bueno-de-Mesquita, H B, Lenner, P, Johansson, M, Jenab, M, Cox, D, Siddiq, A, Kaaks, R & Canzian, F 2011, ' Genetic variability of the forkhead box O3 and prostate cancer risk in the European Prospective Investigation on Cancer ', Oncology Reports, vol. 26, no. 4, pp. 979-986 . https://doi.org/10.3892/or.2011.1359
Accession number :
edsair.doi.dedup.....4ce2755e1e004ce321d3494a59e2e4ce